RPE cells
Stargardt's disease Soraprazan
Soraprazan treatment
removal of lipofuscin
Abnormal accumulation of lipofuscin
new regenerative therapy
Stargardtâ€™s disease
eyes results
project
efficacy
existing therapies
degradation
hallmark
worsening of visual acuity
savety
phase
trial
blindness
placebo